139 related articles for article (PubMed ID: 15654835)
1. Autoantibodies directed against the protease inhibitor calpastatin in psoriasis.
Matsushita Y; Shimada Y; Kawara S; Takehara K; Sato S
Clin Exp Immunol; 2005 Feb; 139(2):355-62. PubMed ID: 15654835
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.
Mimori T; Suganuma K; Tanami Y; Nojima T; Matsumura M; Fujii T; Yoshizawa T; Suzuki K; Akizuki M
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7267-71. PubMed ID: 7638179
[TBL] [Abstract][Full Text] [Related]
3. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y
J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213
[TBL] [Abstract][Full Text] [Related]
4. [Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance].
Yasuoka H; Sugano Y; Oka T; Watanabe C; Kaneko Y; Nojima T; Matsumura M; Fujii T; Mimori T
Ryumachi; 1997 Jun; 37(3):458-66. PubMed ID: 9256029
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
[TBL] [Abstract][Full Text] [Related]
6. Detection of psoriasin/S100A7 in the sera of patients with psoriasis.
Anderson KS; Wong J; Polyak K; Aronzon D; Enerbäck C
Br J Dermatol; 2009 Feb; 160(2):325-32. PubMed ID: 19016707
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis.
Vittecoq O; Salle V; Jouen-Beades F; Krzanowska K; Ménard JF; Gayet A; Fardellone P; Tauveron P; Le Loët X; Tron F
Rheumatology (Oxford); 2001 Oct; 40(10):1126-34. PubMed ID: 11600742
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
Auger I; Roudier C; Guis S; Balandraud N; Roudier J
Ann Rheum Dis; 2007 Dec; 66(12):1588-93. PubMed ID: 17324966
[TBL] [Abstract][Full Text] [Related]
9. [Detection of isotype-specific autoantibodies to calpastatin in sera from patients with rheumatic diseases using heat-treated HeLa cell extract as an antigen source for immunoblotting].
Takada R; Matsumoto M; Yosida M; Nojima T; Hirakata M; Ohosone Y; Mimori T
Nihon Rinsho Meneki Gakkai Kaishi; 1998 Aug; 21(4):150-8. PubMed ID: 9793376
[TBL] [Abstract][Full Text] [Related]
10. [Anti-calpastatin antibody as a serological marker for the diagnosis of rheumatoid arthritis].
Matsuno H; Ochiai A; Iwaki-Egawa S; Watanabe Y
Nihon Rinsho; 2005 Jan; 63 Suppl 1():344-50. PubMed ID: 15799375
[No Abstract] [Full Text] [Related]
11. [Rheumatoid arthritis-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, anti-FRP antibodies)].
Kubota T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():488-90. PubMed ID: 20942110
[No Abstract] [Full Text] [Related]
12. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera.
Lackner KJ; Schlosser U; Lang B; Schmitz G
Br J Rheumatol; 1998 Nov; 37(11):1164-71. PubMed ID: 9851263
[TBL] [Abstract][Full Text] [Related]
15. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating anti-α6-integrin autoantibodies in psoriasis and psoriatic arthritis but not in rheumatoid arthritis.
Gál B; Dulic S; Kiss M; Groma G; Kovács L; Kemény L; Bata-Csörgő Z
J Dermatol; 2017 Apr; 44(4):370-374. PubMed ID: 27790752
[TBL] [Abstract][Full Text] [Related]
18. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
[TBL] [Abstract][Full Text] [Related]
19. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases.
Sánchez D; Tucková L; Sebo P; Michalak M; Whelan A; Sterzl I; Jelínková L; Havrdová E; Imramovská M; Benes Z; Krupicková S; Tlaskalová-Hogenová H
J Autoimmun; 2000 Dec; 15(4):441-9. PubMed ID: 11090243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
